The Valley Desk

Clinical trial reportThe Lancet. HaematologyPublished

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Lancet. Haematology
Published
Subject terms
Humans; Lymphoma; Epistaxis; Heart Arrest; Thrombosis; Pyrazoles; Pyridones; Anticoagulants; Treatment Outcome; Child; Female; Male
PubMed ID
37980924
Added to directory
Source checked

Report a correction or request removal